Clinical Trials Directory

Trials / Completed

CompletedNCT05100355

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy

Management of the Lack of Blood Return on a Central Venous Catheter (CVC) Before Chemotherapy in a Day Unit: Phase III Randomised Multicentre Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Institut Cancerologie de l'Ouest · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare two methods of managing the lack of CVC blood return : opacification using contrast media injection or radio-clinical method with a simple chest X-ray followed by a rapid infusion of physiological serum

Detailed description

The use of CVC is part of daily life in onco-hematology, particularly for chemotherapy treatments in the Day Unit (DU). Among the possible complications and dysfunctions, the most frequent is the lack of CVC blood return, which can be responsible for a disorganization of the patient's management in the Day Unit (delay in patient management). In this study, the 2 most commonly used schemes are compared in a randomised multicentre study. The first scheme is a radiological circuit with opacification using contrast media injection. The second scheme is radio-clinical with a chest X-ray to check the correct functioning of the CVC followed by a rapid infusion of physiological serum. The patient management is compared for the two schemes in term of delay (delay from start to end time of patient management). The safety and the cost of both schemes is compared.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhysiological serum injectionIn case of lack of CVC blood return, Physiological serum is injected in the CVC after Chest X-Ray
PROCEDUREContrast agent injectionIn case of lack of CVC blood return, Contrast agent is injected in the CVC after Chest X-Ray

Timeline

Start date
2022-03-09
Primary completion
2025-02-26
Completion
2025-06-26
First posted
2021-10-29
Last updated
2025-12-02

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05100355. Inclusion in this directory is not an endorsement.